SCHEMBL8333962

SCHEMBL8333962

CCCCCC(N=S(=O)=O)C(C(=O)NC(=S)NC)c1ccc(C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ MMP2 P08253 3/20 0.31
▸ MMP1 P03956 2/20 0.31
▸ MMP3 P08254 2/20 0.31
▸ TNF P01375 1/20 0.31
▸ ADAM17 P78536 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ SCN5A Q14524 1/20 0.31
▸ SCN2A Q99250 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340828 0.99 KDM4E (0.36) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8340568 0.99 KDM4E (0.36) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8334941 0.78 KMT2A (0.39) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8340341 0.78 KDM4E (0.36) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8334654 0.77 MMP1 (0.46) MMP2MMP1MMP3TNFADAM17
SCHEMBL8339878 0.75 ALDH1A1 (0.33) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8338863 0.74 ALDH1A1 (0.35) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8338337 0.73 GAA (0.35) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8339028 0.71 GAA (0.33) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL8334670 0.71 MMP9 (0.41) KDM4EHTTTDP1MMP2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback